Tirzepatide

$ 70

Dual GIP/GLP-1 Receptor Agonist Research Peptide

Tirzepatide is a synthetic dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for research involving metabolic regulation, energy balance, and nutrient utilization. In laboratory settings, it is studied for its ability to activate both incretin receptor pathways, influencing insulin signaling, appetite regulation, gastric emptying, and body composition.

By targeting both GIP and GLP-1 receptors simultaneously, Tirzepatide has become a significant focus in metabolic and obesity-related research models investigating energy homeostasis and glucose metabolism.

This compound is supplied at >99% purity and is independently third-party lab tested to verify identity and analytical standards.

SKU: N/A Category:

Bulk and Kit Pricing Available, Contact Us For Details.

Description

Scientific Background

Tirzepatide selectively activates both GIP and GLP-1 receptors, initiating signaling pathways involved in glucose regulation, satiety, insulin secretion, and energy metabolism. In controlled research settings, it has been evaluated for:

  • Dual incretin receptor activation models
  • Appetite regulation and satiety signaling studies
  • Glucose metabolism and insulin response pathways
  • Body composition and adipose tissue research
  • Energy expenditure and nutrient partitioning models
  • Metabolic efficiency and weight management investigations

 

Its dual-receptor mechanism distinguishes Tirzepatide from single-pathway incretin analogs, making it a valuable research tool for studying integrated metabolic signaling and endocrine regulation under controlled laboratory conditions.
Peer-reviewed publications indexed through the National Library of Medicine include investigations examining dual GIP/GLP-1 receptor agonists and their effects on metabolic signaling, body composition, and glucose regulation in laboratory research.
References available upon request for laboratory review.

Why Researchers Select Tirzepatide

  • Studied for dual GIP/GLP-1 receptor activation
  • Investigated in metabolic and body composition research
  • Explored for appetite regulation and satiety signaling
  • Evaluated for glucose metabolism and insulin response pathways
  • Compatible with structured endocrine and metabolic research protocols

 

Product Specifications

  • 99% purity – independently third-party lab tested
  • Supplied as high-quality lyophilized powder
  • Requires reconstitution prior to laboratory use
  • Bacteriostatic water required for mixing (sold separately)
  • Swirl gently to dissolve—do not shake
  • Ensure complete dissolution before handling

 

Storage Guidelines

  • Store the lyophilized vial under freezer conditions until use
  • Maintain at 2–8°C and protect from light after reconstitution
  • Refrigerate following reconstitution
  • Use within standard laboratory handling timeframes

 

Research Use Notice

For laboratory research purposes only. Not for human consumption, therapeutic, or veterinary use.

Additional information

Dosage

40mg

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.